cefteram-pivoxil and Urinary-Tract-Infections

cefteram-pivoxil has been researched along with Urinary-Tract-Infections* in 2 studies

Other Studies

2 other study(ies) available for cefteram-pivoxil and Urinary-Tract-Infections

Article	Year
[Identification of pivaloylcarnitine in urine of patients with pivoxil therapy]. No to hattatsu = Brain and development, 1992, Volume: 24, Issue:5 Topics: Administration, Oral; Adolescent; Carnitine; Cefmenoxime; Humans; Urinary Tract Infections	1992
[Clinical experience with T-2588 in complicated urinary tract infections]. Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:7 The clinical effectiveness and safety of T-2588 were evaluated in 21 patients with complicated urinary tract infections. Six hundred mg of T-2588 per day was administered orally in three divided doses for 14 days. The results were excellent in 7 cases (33.3%), moderate in 8 cases (38.1%) and poor in 6 cases (28.6%), and the effectiveness rate was 71.4%. The effectiveness rates of the single infection group and mixed infection group were 91.7% and 44.4%, respectively. The overall bacteriological eradication rate obtained was 77.1%, and those of gram-positive cocci and gram-negative rods were 62.5% and 81.5%, respectively. None of the 21 cases, had any significant side effects and abnormal laboratory findings. From the above results, T-2588 is considered to be a useful antibiotic in the treatment of complicated urinary tract infections. Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; Cefmenoxime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Urinary Tract Infections	1986

Article

Year

[Identification of pivaloylcarnitine in urine of patients with pivoxil therapy].

No to hattatsu = Brain and development, 1992, Volume: 24, Issue:5

Topics: Administration, Oral; Adolescent; Carnitine; Cefmenoxime; Humans; Urinary Tract Infections

1992

[Clinical experience with T-2588 in complicated urinary tract infections].

Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:7

The clinical effectiveness and safety of T-2588 were evaluated in 21 patients with complicated urinary tract infections. Six hundred mg of T-2588 per day was administered orally in three divided doses for 14 days. The results were excellent in 7 cases (33.3%), moderate in 8 cases (38.1%) and poor in 6 cases (28.6%), and the effectiveness rate was 71.4%. The effectiveness rates of the single infection group and mixed infection group were 91.7% and 44.4%, respectively. The overall bacteriological eradication rate obtained was 77.1%, and those of gram-positive cocci and gram-negative rods were 62.5% and 81.5%, respectively. None of the 21 cases, had any significant side effects and abnormal laboratory findings. From the above results, T-2588 is considered to be a useful antibiotic in the treatment of complicated urinary tract infections.

Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; Cefmenoxime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Urinary Tract Infections

1986